What are the Therapeutic Implications of Targeting LANA?
Targeting LANA offers a promising therapeutic approach for treating KSHV-associated cancers. By inhibiting LANA function, it may be possible to disrupt the maintenance of viral latency and promote the clearance of infected cells. Research is ongoing to develop drugs that specifically target LANA or its interactions with host cell proteins. Additionally, antiviral therapies aimed at reducing KSHV load could indirectly impact LANA-associated oncogenesis.
